Novel Approaches for Development of Human Immunodeficiency Virus Preexposure Prophylaxis Agents.
作者信息
Cohen Myron S, Donnell Deborah
机构信息
Institute for Global Health and Infectious Diseases, School of Medicine, University of North Carolina at Chapel Hill.
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
出版信息
J Infect Dis. 2020 Jan 2;221(2):172-174. doi: 10.1093/infdis/jiz041.
Abstract
摘要
相似文献
1
Novel Approaches for Development of Human Immunodeficiency Virus Preexposure Prophylaxis Agents.开发人类免疫缺陷病毒暴露前预防药物的新方法。
J Infect Dis. 2020 Jan 2;221(2):172-174. doi: 10.1093/infdis/jiz041.
2
Moving Forward With Treatment of Gonorrhea for Users of Human Immunodeficiency Virus Preexposure Prophylaxis Given the Threat of Antimicrobial Resistance.鉴于抗菌药物耐药性的威胁，推进针对接受人类免疫缺陷病毒暴露前预防的使用者的淋病治疗
Clin Infect Dis. 2018 Jun 18;67(1):155-156. doi: 10.1093/cid/ciy050.
3
Assessing the Impact of HIV Preexposure Prophylaxis Scale-Up on Gonorrhea Incidence Among Gay and Bisexual Men in Sydney: A Mathematical Modeling Study.评估扩大艾滋病毒暴露前预防措施对悉尼男同性恋者和双性恋男性淋病发病率的影响：一项数学建模研究。
Sex Transm Dis. 2022 Aug 1;49(8):534-540. doi: 10.1097/OLQ.0000000000001649. Epub 2022 May 24.
4
Correlations Between Human Immunodeficiency Virus (HIV) Infection and Rectal Gonorrhea Incidence in Men Who Have Sex With Men: Implications for Future HIV Preexposure Prophylaxis Trials.人类免疫缺陷病毒（HIV）感染与男男性行为者中直肠淋病发病率的相关性：对未来 HIV 暴露前预防试验的启示。
J Infect Dis. 2020 Jan 2;221(2):214-217. doi: 10.1093/infdis/jiz037.
5
Prescription of Preexposure Prophylaxis to Men Who Have Sex With Men Diagnosed and Reported With Gonorrhea, STD Surveillance Network, 2016.2016 年，男男性行为者淋病诊断和报告后，性传播疾病监测网络中对其开展的暴露前预防用药处方情况。
Sex Transm Dis. 2018 Aug;45(8):e57-e60. doi: 10.1097/OLQ.0000000000000812.
6
Incidence of Hepatitis C Virus Infections Among Users of Human Immunodeficiency Virus Pre-exposure Prophylaxis.接受人类免疫缺陷病毒暴露前预防的人群中丙型肝炎病毒感染的发生率
Clin Gastroenterol Hepatol. 2022 Mar;20(3):674-681. doi: 10.1016/j.cgh.2021.03.006. Epub 2021 Mar 16.
7
Low incidence of HIV infection and decreasing incidence of sexually transmitted infections among PrEP users in 2020 in Germany.2020 年德国接受暴露前预防（PrEP）的人群中 HIV 感染和性传播感染发病率较低。
Infection. 2023 Jun;51(3):665-678. doi: 10.1007/s15010-022-01919-3. Epub 2022 Sep 27.
8
Low Prior Exposure and Incidence of Hepatitis C in Human Immunodeficiency Virus-Negative Gay and Bisexual Men Taking Preexposure Prophylaxis (PrEP): Findings From the Expanded PrEP Implementation in Communities-New South Wales Prospective Implementation Study.低前期暴露和丙型肝炎发病率在艾滋病毒阴性男同性恋和双性恋男性中采取暴露前预防（PrEP）：从社区中扩大 PrEP 实施的新南威尔士州前瞻性实施研究中的发现。
Clin Infect Dis. 2022 Oct 29;75(9):1497-1502. doi: 10.1093/cid/ciac231.
9
The Impact of Pre-exposure Prophylaxis for Human Immunodeficiency Virus on Gonorrhea Prevalence.暴露前预防人类免疫缺陷病毒对淋病发病率的影响。
Bull Math Biol. 2020 Jul 1;82(7):85. doi: 10.1007/s11538-020-00762-7.
10
Pharyngeal Chlamydia trachomatis in Men Who Have Sex With Men in a Human Immunodeficiency Virus (HIV) Pre-exposure Prophylaxis Program in Hanoi, Vietnam.越南河内一项人类免疫缺陷病毒（HIV）暴露前预防项目中男男性行为者的咽部沙眼衣原体感染情况
Clin Infect Dis. 2022 Nov 30;75(11):2045-2046. doi: 10.1093/cid/ciac618.
引用本文的文献
1
Estimating counterfactual placebo HIV incidence in HIV prevention trials without placebo arms based on markers of HIV exposure.基于 HIV 暴露标志物估计无安慰剂对照臂的 HIV 预防试验中的反事实安慰剂 HIV 发病率。
Clin Trials. 2024 Feb;21(1):114-123. doi: 10.1177/17407745231203327. Epub 2023 Oct 25.
本文引用的文献
1
Correlations Between Human Immunodeficiency Virus (HIV) Infection and Rectal Gonorrhea Incidence in Men Who Have Sex With Men: Implications for Future HIV Preexposure Prophylaxis Trials.人类免疫缺陷病毒（HIV）感染与男男性行为者中直肠淋病发病率的相关性：对未来 HIV 暴露前预防试验的启示。
J Infect Dis. 2020 Jan 2;221(2):214-217. doi: 10.1093/infdis/jiz037.
2
The averted infections ratio: a novel measure of effectiveness of experimental HIV pre-exposure prophylaxis agents.避免感染率：一种评估实验性 HIV 暴露前预防药物效果的新指标。
Lancet HIV. 2018 Jun;5(6):e329-e334. doi: 10.1016/S2352-3018(18)30045-6.
3
HIV Population Surveys - Bringing Precision to the Global Response.HIV人群调查——让全球应对措施更加精准。
N Engl J Med. 2018 May 17;378(20):1859-1861. doi: 10.1056/NEJMp1801934.
4
HIV prevention trial design in an era of effective pre-exposure prophylaxis.有效暴露前预防时代的艾滋病病毒预防试验设计
HIV Clin Trials. 2017 Nov-Dec;18(5-6):177-188. doi: 10.1080/15284336.2017.1379676. Epub 2017 Oct 17.
5
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.按需暴露前预防治疗在 HIV-1 感染高危男性中的应用。
N Engl J Med. 2015 Dec 3;373(23):2237-46. doi: 10.1056/NEJMoa1506273. Epub 2015 Dec 1.
6
Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.暴露前预防以预防HIV-1感染（PROUD）：一项实用开放标签随机试验试点阶段的有效性结果
Lancet. 2016 Jan 2;387(10013):53-60. doi: 10.1016/S0140-6736(15)00056-2. Epub 2015 Sep 9.
7
No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting.在临床实践环境中，随着艾滋病病毒暴露前预防措施使用的增加，新的艾滋病病毒感染病例未出现增长。
Clin Infect Dis. 2015 Nov 15;61(10):1601-3. doi: 10.1093/cid/civ778. Epub 2015 Sep 1.
8
The high risk of an HIV diagnosis following a diagnosis of syphilis: a population-level analysis of New York City men.梅毒诊断后 HIV 诊断的高风险：纽约市男性的人群水平分析。
Clin Infect Dis. 2015 Jul 15;61(2):281-7. doi: 10.1093/cid/civ289. Epub 2015 Apr 13.
9
HIV transmission. Selection bias at the heterosexual HIV-1 transmission bottleneck.HIV 传播。异性恋 HIV-1 传播瓶颈处的选择偏倚。
Science. 2014 Jul 11;345(6193):1254031. doi: 10.1126/science.1254031. Epub 2014 Jul 10.
10
Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men.接受暴露前预防（PrEP）的男男性行为者的恩曲他滨替诺福韦浓度与预防效果。
Sci Transl Med. 2012 Sep 12;4(151):151ra125. doi: 10.1126/scitranslmed.3004006.
Zotero 插件